Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation

Park,Kyungho; Ju,Won-Chul; Yeo,Joo-Hong; Kim,Jong   Youl; Seo,Ho   Seong; Uchida,Yoshikazu; Cho,Yunhi

doi:10.3892/ijmm.2013.1557

Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation

Authors:
- Kyungho Park
- Won-Chul Ju
- Joo-Hong Yeo
- Jong Youl Kim
- Ho Seong Seo
- Yoshikazu Uchida
- Yunhi Cho
View Affiliations

Affiliations: Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi 446-701, Republic of Korea, Sericultural and Apicultural Materials Division, National Academy of Agricultural Science, RDA, Suwon, Gyeonggi 441-100, Republic of Korea, Department of Endocrinology, School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA 94158, USA, Radiation Research Division, Korea Atomic Energy Research Institute, Jeongeup, Jeonbuk 580-185, Republic of Korea, Department of Dermatology, School of Medicine, University of California, San Francisco (UCSF), San Francisco, CA 94158, USA
Published online on: November 18, 2013 https://doi.org/10.3892/ijmm.2013.1557
Pages: 178-184

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Soybean is a major dietary source of isoflavones, particularly daidzein and genistein, which stimulate osteoblastic functions that are initiated by binding to estrogen receptor (ER)-α and ER-β found on osteoblasts. However, coupled with a low expression of ER-α and ER-β in osteoclasts, the inhibitory effects of soy isoflavones on osteoclast differentiation is likely mediated through paracrine factors produced by osteoblasts. Therefore, in this study, we investigated whether soybean can indirectly inhibit osteoclast differentiation through the modulation of osteoclastic factors produced by osteoblasts. Treatment with soybean extracts increased the levels of osteoprotegerin (OPG) and decreased those of receptor activator of nuclear factor-κB ligand (RANKL) in the conditioned medium (CM) of MC3T3-E1 osteoblasts. Subsequently, the RANKL-induced RAW264.7 osteoclast formation was markedly inhibited by treatment with CM collected from MC3T3-E1 osteoblasts incubated with soybean extracts (S-CM). Similarly, S-CM significantly attenuated the RANKL-induced increase in the mRNA and protein levels of matrix metalloproteinase-9 (MMP-9), a potential biomarker gene of osteoclast differentiation, through the suppression of nuclear factor of activated T cells c1 (NFATc1) activation. Of note, a soybean concentration of 0.001 mg/ml further increased the OPG/RANKL ratio compared to treatment with a 0.1 mg/ml soybean concentration and was overall, more effective at inhibiting RANKL-induced osteoclast formation and MMP-9 expression. Taken together, our data demonstrate that treatment with soybean extracts stimulates the secretion of OPG and inhibits that of RANKL, thus inhibiting RANKL-induced osteoclast differentiation through the suppression of NFATc1 activation.

View Figures

View References

1	Spelsberg TC, Subramaniam M, Riggs BL and Khosla S: The actions and interactions of sex steroids and growth factor/cytokines on the skeleton. Mol Endocrinol. 13:819–828. 1999. View Article : Google Scholar : PubMed/NCBI
2	Barton M and Shapiro D: Transient administration of estradiol-17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. Proc Natl Acad Sci USA. 85:7119–7123. 1998. View Article : Google Scholar : PubMed/NCBI
3	Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R and Doevendans PA: Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res. 53:709–719. 2002. View Article : Google Scholar : PubMed/NCBI
4	Kang KS, Morita I, Cruz A, Jeon YJ, Trosko JE and Chang CC: Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis. 18:251–257. 1997. View Article : Google Scholar : PubMed/NCBI
5	Lindgren PR, Cajander S, Bäckström T, Gustafsson JA, Mäkelä S and Olofsson JI: Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol. 221:97–104. 2004. View Article : Google Scholar : PubMed/NCBI
6	Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS: Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 138:4613–4621. 1997.
7	Ernst M, Schmid C and Froesch ER: Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA. 85:2307–2310. 1988. View Article : Google Scholar : PubMed/NCBI
8	Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y and Matsumoto T: Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 143:2349–2356. 2002.
9	Balica M, Boström K, Shin V, Tillisch K and Demer LL: Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation. 95:1954–1960. 1997. View Article : Google Scholar : PubMed/NCBI
10	Bord S, Ireland DC, Beavan SR and Compston JE: The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone. 32:136–141. 2003. View Article : Google Scholar : PubMed/NCBI
11	Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y and Kumegawa M: Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 186:489–495. 1997. View Article : Google Scholar : PubMed/NCBI
12	Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL, Zheng MH and Nicholson GC: Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology. 139:1258–1267. 1998.PubMed/NCBI
13	Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH and Speizer FE: Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1769–1775. 1997. View Article : Google Scholar : PubMed/NCBI
14	Compston JE: Sex steroids and bone. Physiol Rev. 81:419–447. 2001.PubMed/NCBI
15	Keinan-Boker L, van Der Schouw YT, Grobbee DE and Peeters PH: Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr. 79:282–288. 2004.PubMed/NCBI
16	Setchell KD and Lydeking-Olsen E: Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr. 78(Suppl 3): 593S–609S. 2003.PubMed/NCBI
17	Kim J, Um SJ, Woo J, Kim JY, Kim HA, Jang KH, Kang SA, Lim BO, Kang I, Choue RW and Cho Y: Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci. 78:30–40. 2005.
18	Qu Q, Härkönen PL, Mönkkönen J and Väänänen HK: Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone. 25:211–215. 1999. View Article : Google Scholar : PubMed/NCBI
19	Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM and Choi Y: The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem. 273:28355–28359. 1998. View Article : Google Scholar : PubMed/NCBI
20	Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T and Takeya T: Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem. 277:41147–41156. 2002. View Article : Google Scholar : PubMed/NCBI
21	Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM and Uchida Y: Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 286:34121–34130. 2011. View Article : Google Scholar
22	Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R and Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
23	Santanam N, Shern-Brewer R, McClatchey R, Castellano PZ, Murphy AA, Voelkel S and Parthasarathy S: Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res. 39:2111–2118. 1998.PubMed/NCBI
24	Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology. 142:5050–5055. 2001. View Article : Google Scholar : PubMed/NCBI
25	Sundaram K, Nishimura R, Senn J, Youssef RF, London SD and Reddy SV: RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 313:168–178. 2007. View Article : Google Scholar : PubMed/NCBI
26	Karieb S and Fox SW: Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J Cell Biochem. 112:476–487. 2011.
27	Tyagi AM, Srivastava K, Sharan K, Yadav D, Maurya R and Singh D: Daidzein prevents the increase in CD4⁺CD28^null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One. 6:e212162011.PubMed/NCBI
28	García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE and Blair HC: Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J Biol Chem. 280:13720–13727. 2005.
29	Lorget F, Kamel S, Mentaverri R, Wattel A, Naassila M, Maamer M and Brazier M: High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun. 268:899–903. 2000. View Article : Google Scholar : PubMed/NCBI
30	Gao YH and Yamaguchi M: Suppressive effect of genistein on rat bone osteoclasts: Involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med. 5:261–267. 2000.PubMed/NCBI
31	Fu YX, Gu JH, Zhang YR, Tong XS, Zhao HY, Yuan Y, Liu XZ, Bian JC and Liu ZP: Osteoprotegerin influences the bone resorption activity of osteoclasts. Int J Mol Med. 31:1411–1417. 2013.PubMed/NCBI
32	Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T and Taniguchi T: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI